TrialCritical care (London, England)2005

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317].

Dimitris Georgopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.